Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

Date Posted: 
2014-09-26

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men.

Co-lead by Drs. Paul Rennie, Art Cherkasov & Emma Tomlinson-Gun, the project "Pre-clinical development of the next-generation anti-androgens for the treatment of drug-resistant and advanced prostate cancer" is one of only two grants awarded. The three-year grant is for $1,463,090 starting on October 1, 2014.

Click here to read the Prostate Cancer Canada press release of this funding award.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember Foundation 2018

Movember 2018

The Movember Foundation's fundraiser runs from November 1 to 30.  Click here to donate to The Vancouver Prostate Centre team as we join teams across Canada to raise funds for men's health research in the areas of prostate cancer, testicular cancer, mental health and suicide prevention.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development